Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 12.97
-0.04 (-0.31%)
Sep 16, 2026, 3:04 PM CST
Walvax Biotechnology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,098 | 2,418 | 2,821 | 4,114 | 5,086 | 3,463 |
Revenue Growth | -17.47% | -14.29% | -31.41% | -19.12% | 46.89% | 17.82% |
Gross Profit Gross Profit Growth | 1,590 | 1,786 | 2,079 | 3,364 | 4,413 | 3,059 |
Operating Income Operating Income Growth | 188.83 | 104.33 | 24.01 | 831.05 | 1,174 | 792.22 |
Net Income Net Income Growth | 188.77 | 177.74 | 142.16 | 419.39 | 728.65 | 427.75 |
Earnings Per Share EPS Growth | 0.12 | 0.11 | 0.09 | 0.26 | 0.45 | 0.27 |
EPS Growth | 1163.86% | 24.97% | -66.08% | -42.32% | 67.12% | -57.74% |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Northeast and North China Northeast and North China Growth | 213.01 | 252.42 |
Eastern China Eastern China Growth | 679.27 | 874.69 |
South China Region South China Region Growth | 400.71 | 404.62 |
Central China Region Central China Region Growth | 256.31 | 332.25 |
Southwest Northwest Region Southwest Northwest Region Growth | 346.88 | 387.18 |
Overseas Region Overseas Region Growth | 522.04 | 570.29 |
Total Total Growth | 2,418 | 2,821 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,189 | 1,665 | 3,764 | 4,365 | 3,873 | 3,443 |
Total Debt Total Debt Growth | 1,299 | 388.63 | 491.94 | 806.42 | 462.51 | 315.67 |
Net Cash (Debt) Net Cash Growth | -109.38 | 1,276 | 3,272 | 3,558 | 3,411 | 3,128 |
Net Cash Growth | - | -61.00% | -8.05% | 4.31% | 9.06% | 62.77% |
Net Cash Per Share Net Cash Per Share Growth | -0.07 | 0.80 | 2.05 | 2.22 | 2.13 | 1.99 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 548.19 | 490.93 | 1,037 | 1,134 | 1,201 | 705.28 |
Capital Expenditures CapEx Growth | -529.76 | -509.54 | -550.03 | -945.52 | -1,091 | -1,103 |
Free Cash Flow Free Cash Flow Growth | 18.43 | -18.62 | 486.49 | 188.25 | 110.31 | -398.21 |
Free Cash Flow Growth | -97.27% | - | 158.43% | 70.65% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 75.76% | 73.87% | 73.69% | 81.78% | 86.77% | 88.35% |
Operating Margin | 9.00% | 4.31% | 0.85% | 20.20% | 23.08% | 22.88% |
Pretax Margin | 10.64% | 6.87% | 6.54% | 14.56% | 21.05% | 20.47% |
Profit Margin | 9.00% | 7.35% | 5.04% | 10.20% | 14.32% | 12.35% |
FCF Margin | 0.88% | -0.77% | 17.24% | 4.58% | 2.17% | -11.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.155 | 0.155 | 0.010 | 0.010 | 0.010 | 0.027 |
Dividend Per Share Growth | 1450.00% | 1450.00% | 0% | 0% | -62.96% | -61.43% |
Dividend Yield | 1.18% | 1.44% | 0.08% | 0.04% | 0.03% | 0.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 110.53 | 98.17 | 135.90 | 89.66 | 88.21 | 209.06 |
Forward PE | - | 50.16 | 37.75 | 42.75 | 54.68 | 56.13 |
P/FCF Ratio | 1125.60 | - | 39.71 | 199.74 | 582.65 | - |
PS Ratio | 9.89 | 7.22 | 6.85 | 9.14 | 12.64 | 25.82 |